These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 1499083)

  • 1. Ascorbate is the principal reductant of chromium(VI) in rat lung ultrafiltrates and cytosols, and mediates chromium-DNA binding in vitro.
    Standeven AM; Wetterhahn KE
    Carcinogenesis; 1992 Aug; 13(8):1319-24. PubMed ID: 1499083
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ascorbate is the principal reductant of chromium (VI) in rat liver and kidney ultrafiltrates.
    Standeven AM; Wetterhahn KE
    Carcinogenesis; 1991 Sep; 12(9):1733-7. PubMed ID: 1893533
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo effects of ascorbate and glutathione on the uptake of chromium, formation of chromium(V), chromium-DNA binding and 8-hydroxy-2'-deoxyguanosine in liver and kidney of osteogenic disorder shionogi rats following treatment with chromium(VI).
    Yuann JM; Liu KJ; Hamilton JW; Wetterhahn KE
    Carcinogenesis; 1999 Jul; 20(7):1267-75. PubMed ID: 10383900
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduction of chromium(VI) by ascorbate leads to chromium-DNA binding and DNA strand breaks in vitro.
    Stearns DM; Kennedy LJ; Courtney KD; Giangrande PH; Phieffer LS; Wetterhahn KE
    Biochemistry; 1995 Jan; 34(3):910-9. PubMed ID: 7827049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential binding of chromium(VI) and chromium(III) complexes to salmon sperm nuclei and nuclear DNA and isolated calf thymus DNA.
    Hneihen AS; Standeven AM; Wetterhahn KE
    Carcinogenesis; 1993 Sep; 14(9):1795-803. PubMed ID: 8403202
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reductive metabolism and protein binding of chromium(VI) by P450 protein enzymes.
    Mikalsen A; Alexander J; Wallin H; Ingelman-Sundberg M; Andersen RA
    Carcinogenesis; 1991 May; 12(5):825-31. PubMed ID: 1903091
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of mannitol or catalase on the generation of reactive oxygen species leading to DNA damage by Chromium(VI) reduction with ascorbate.
    Tsou TC; Lai HJ; Yang JL
    Chem Res Toxicol; 1999 Oct; 12(10):1002-9. PubMed ID: 10525278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carcinogenic chromium(VI) induces cross-linking of vitamin C to DNA in vitro and in human lung A549 cells.
    Quievryn G; Messer J; Zhitkovich A
    Biochemistry; 2002 Mar; 41(9):3156-67. PubMed ID: 11863455
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genotoxicity and mutagenicity of chromium(VI)/ascorbate-generated DNA adducts in human and bacterial cells.
    Quievryn G; Peterson E; Messer J; Zhitkovich A
    Biochemistry; 2003 Feb; 42(4):1062-70. PubMed ID: 12549927
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chromium(VI) reduction by ascorbate: role of reactive intermediates in DNA damage in vitro.
    Stearns DM; Courtney KD; Giangrande PH; Phieffer LS; Wetterhahn KE
    Environ Health Perspect; 1994 Sep; 102 Suppl 3(Suppl 3):21-5. PubMed ID: 7843100
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prominent role of DT-diaphorase as a cellular mechanism reducing chromium(VI) and reverting its mutagenicity.
    De Flora S; Morelli A; Basso C; Romano M; Serra D; De Flora A
    Cancer Res; 1985 Jul; 45(7):3188-96. PubMed ID: 4005852
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apoptosis and P53 induction in human lung fibroblasts exposed to chromium (VI): effect of ascorbate and tocopherol.
    Carlisle DL; Pritchard DE; Singh J; Owens BM; Blankenship LJ; Orenstein JM; Patierno SR
    Toxicol Sci; 2000 May; 55(1):60-8. PubMed ID: 10788560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathways of Cr (III) and Cr (VI) in the rat after intratracheal administration.
    Edel J; Sabbioni E
    Hum Toxicol; 1985 Jul; 4(4):409-16. PubMed ID: 4018821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chromium(VI) causes interstrand DNA cross-linking in vitro but shows no hypersensitivity in cross-link repair-deficient human cells.
    Morse JL; Luczak MW; Zhitkovich A
    Chem Res Toxicol; 2013 Oct; 26(10):1591-8. PubMed ID: 24059640
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chromium (VI) reducing capacity of ascorbic acid and of human plasma in vitro.
    Capellmann M; Bolt HM
    Arch Toxicol; 1992; 66(1):45-50. PubMed ID: 1580793
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Different ATM Signaling in Response to Chromium(VI) Metabolism via Ascorbate and Nonascorbate Reduction: Implications for in Vitro Models and Toxicogenomics.
    Luczak MW; Green SE; Zhitkovich A
    Environ Health Perspect; 2016 Jan; 124(1):61-6. PubMed ID: 25977998
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Critical role of chromium (Cr)-DNA interactions in the formation of Cr-induced polymerase arresting lesions.
    O'Brien T; Mandel HG; Pritchard DE; Patierno SR
    Biochemistry; 2002 Oct; 41(41):12529-37. PubMed ID: 12369844
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Undetectable role of oxidative DNA damage in cell cycle, cytotoxic and clastogenic effects of Cr(VI) in human lung cells with restored ascorbate levels.
    Reynolds M; Armknecht S; Johnston T; Zhitkovich A
    Mutagenesis; 2012 Jul; 27(4):437-43. PubMed ID: 22241526
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pro-oxidative vs antioxidative properties of ascorbic acid in chromium(VI)-induced damage: an in vivo and in vitro approach.
    Poljsak B; Gazdag Z; Jenko-Brinovec S; Fujs S; Pesti M; Bélagyi J; Plesnicar S; Raspor P
    J Appl Toxicol; 2005; 25(6):535-48. PubMed ID: 16092082
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro reduction of Cr(VI) by low molecular weight biomimetic components: a comparative study using UV-Vis spectroscopy.
    Kaiwar SP; Rao CP
    Chem Biol Interact; 1995 Mar; 95(1-2):89-96. PubMed ID: 7697756
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.